Health

J&J, AstraZeneca explore COVID-19 vaccine modification after blood clot reports – WSJ – Financial Post

Johnson & Johnson and AstraZeneca are conducting early research into whether modifications to their COVID-19 vaccines could eliminate…

Published

4 years ago

July 13, 2021

Noosa Online News Publisher

Johnson & Johnson and AstraZeneca are conducting early research into whether modifications to their COVID-19 vaccines could eliminate or reduce the risk of rare blood clots linked to the shots, the Wall Street Journal reported, citing people close to the…

Click here to view the original article.

Related Topics:Australia Financial Post

Up Next

Researchers publish promising results for ultra-rare disease gene therapy method – PMLiVE

Don't Miss

Islamic Republic of Iran focuses on innovative approaches in essential mental health services amid COVID-19 pandemic – Iran (Islamic Republic of) – ReliefWeb

General18 hours ago

ARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate

Noosa News18 hours ago

Police officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial

General20 hours ago

Perth man charged after investigation into organised crime and tobacco store attacks

General15 hours ago

Russian barrage kills 25 in Ukraine city as Zelenskyy holds talks with Turkish leader

Noosa Online News

J&J, AstraZeneca explore COVID-19 vaccine modification after blood clot reports – WSJ – Financial Post

Trending